EJCTS Click here for details of sales representative
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Valen, G.
Right arrow Articles by Vaage, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Valen, G.
Right arrow Articles by Vaage, J.

European Journal of Cardio-Thoracic Surgery, Vol 8, 324-330, Copyright © 1994 by European Association for Cardio-thoracic Surgery

ARTICLES

Fibrinolysis during cardiac surgery. Release of tissue plasminogen activator in arterial and coronary sinus blood

G Valen, E Eriksson, B Risberg and J Vaage
Department of Thoracic Surgery, Karolinska Hospital, Stockholm, Sweden.

Endothelial release of tissue plasminogen activator (t-PA) may initiate fibrinolysis. Fibrinolysis and coagulation were investigated in 12 patients undergoing elective coronary artery bypass surgery. Cardiopulmonary bypass (CPB) was 108 +/- 7 min (mean +/- SEM), the time of cold, crystalloid, retrograde cardioplegia 53 +/- 5 min. Arterial and coronary sinus blood were sampled concomitantly before cardioplegia and after release of the aortic cross-clamp, for measurement of t-PA antigen (Ag) and activity, plasminogen activator inhibitor (PAI-1) Ag and activity, t-PA/PAI-1 complex, single chain urokinase (sc-uPA) and urokinase (uPA) plasminogen activators, the fibrin split product D- dimer, thrombin-antithrombin complex (TAT), and the prothrombin split product F 1 + 2. Cardiopulmonary bypass significantly increased t-PA Ag and activity, t-PA/PAI complex, D-dimer, TAT, and F 1 + 2, and decreased PAI-1 Ag and activity in arterial blood; uPA and sc-uPA were unchanged. The tissue plasminogen activator antigen was higher in coronary sinus than arterial blood after 1 (39 +/- 5 vs 24 +/- 4 ng/ml, P < 0.003), 4 (P < 0.003), and 10 min (P < 0.004) reperfusion. Tissue plasminogen activator activity and t-PA/PAI complex increased, PAI-1 activity decreased, while all other parameters were unchanged across the coronary circulation. In conclusion, CPB induces fibrinolysis and coagulation. Cold cardioplegia induces t-PA release in the coronary circulation, denoting a postischemic antithrombotic function of the coronary endothelium. Tissue plasminogen activator may be used to evaluate endothelial stimulation or injury induced by CPB, or by different regimens of myocardial protection.


This article has been cited by other articles:


Home page
 Anesth. Analg.Home page
E. Duggan, M. J. O'Dwyer, E. Caraher, D. Diviney, E. McGovern, D. Kelleher, R. McManus, and T. Ryan
Coagulopathy After Cardiac Surgery May Be Influenced by a Functional Plasminogen Activator Inhibitor Polymorphism
Anesth. Analg., June 1, 2007; 104(6): 1343 - 1347.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
A. M. Morariu, Y. J. Gu, R. C.G. G. Huet, W. A. Siemons, G. Rakhorst, and W. v. Oeveren
Red blood cell aggregation during cardiopulmonary bypass: a pathogenic cofactor in endothelial cell activation?
Eur. J. Cardiothorac. Surg., November 1, 2004; 26(5): 939 - 946.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
B. S. Donahue
Factor V Leiden and Perioperative Risk
Anesth. Analg., June 1, 2004; 98(6): 1623 - 1634.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
M. J. Eisses, K. Seidel, G. S. Aldea, and W. L. Chandler
Reducing Hemostatic Activation During Cardiopulmonary Bypass: A Combined Approach
Anesth. Analg., May 1, 2004; 98(5): 1208 - 1216.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
A. Wahba and V. Videm
Heart surgery with extracorporeal circulation leads to platelet activation at the time of hospital discharge
Eur. J. Cardiothorac. Surg., June 1, 2003; 23(6): 1046 - 1050.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
R. M. Engelman, A. B. Pleet, J. A. Rousou, J. E. Flack III, D. W. Deaton, P. S. Pekow, and C. A. Gregory
Influence of cardiopulmonary bypass perfusion temperature on neurologic and hematologic function after coronary artery bypass grafting
Ann. Thorac. Surg., June 1, 1999; 67(6): 1547 - 1555.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
B. J. Hunt, R. N. Parratt, H. C. Segal, S. Sheikh, P. Kallis, and M. Yacoub
Activation of Coagulation and Fibrinolysis During Cardiothoracic Operations
Ann. Thorac. Surg., March 1, 1998; 65(3): 712 - 718.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
S. Cicek, U. Demirkilic, E. Ozal, E. Kuralay, H. Bingol, H. Tatar, and O. Y. Ozturk
POSTOPERATIVE USE OF APROTININ IN CARDIAC OPERATIONS: AN ALTERNATIVE TO ITS PROPHYLACTIC USE
J. Thorac. Cardiovasc. Surg., December 1, 1996; 112(6): 1462 - 1467.
[Abstract] [Full Text]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
R. M. Engelman, A. B. Pleet, J. A. Rousou, J. E. Flack III, D. W. Deaton, C. A. Gregory, and P. S. Pekow
WHAT IS THE BEST PERFUSION TEMPERATURE FOR CORONARY REVASCULARIZATION?
J. Thorac. Cardiovasc. Surg., December 1, 1996; 112(6): 1622 - 1633.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1994 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.